Compile Data Set for Download or QSAR
Report error Found 50 Enz. Inhib. hit(s) with all data for entry = 50020537
LigandPNGBDBM50134840((S)-2-Ethoxy-3-[4-((E)-5-phenyl-pent-2-en-4-ynylox...)
Affinity DataEC50:  6.40E+3nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214967((Z)-2-(4-(4-(4-bromophenyl)-7-(1H-pyrazol-1-yl)hep...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM28681(cid_5281055 | [3H]rosiglitazone | CHEMBL121 | ROSI...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214960((Z)-2-(2-methyl-4-(4-(2-methylbenzofuran-5-yl)-6-(...)
Affinity DataEC50:  5.80E+3nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214966((Z)-2-(4-(4-(4-bromophenyl)-6-(pyridin-2-yl)hex-2-...)
Affinity DataEC50:  240nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214964((Z)-2-(2-methyl-4-(4-(4-(5-methylthiophen-2-yl)phe...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214952({4-[(Z)-4-biphenyl-4-yl-6-(4-methoxy-phenyl)-hex-2...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214954((Z)-2-(2-methyl-4-(6-phenyl-4-(quinolin-3-yl)hex-2...)
Affinity DataEC50:  4.10E+3nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214955((Z)-2-(4-(4-(4-bromophenyl)-6-(4-fluoro-3-methylph...)
Affinity DataEC50:  2.00E+3nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM28661(GW501516 | CHEMBL38943 | 2-{2-methyl-4-[({4-methyl...)
Affinity DataEC50:  8nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM28681(cid_5281055 | [3H]rosiglitazone | CHEMBL121 | ROSI...)
Affinity DataEC50:  300nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214965((Z)-2-(4-(4-(4-bromophenyl)-7-morpholinohept-2-en-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214968((Z)-2-(4-(6-(4-fluorophenyl)-4-(2-methylbenzofuran...)
Affinity DataEC50:  290nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214965((Z)-2-(4-(4-(4-bromophenyl)-7-morpholinohept-2-en-...)
Affinity DataEC50:  3.00E+3nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214959((Z)-2-(4-(4-(4-bromophenyl)-6-(4-(hydroxymethyl)ph...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50134840((S)-2-Ethoxy-3-[4-((E)-5-phenyl-pent-2-en-4-ynylox...)
Affinity DataEC50:  10nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214966((Z)-2-(4-(4-(4-bromophenyl)-6-(pyridin-2-yl)hex-2-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214951((Z)-[4-[3-(4-4-bromophenyl)-5-(4-trifluoromethyl-p...)
Affinity DataEC50:  130nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214965((Z)-2-(4-(4-(4-bromophenyl)-7-morpholinohept-2-en-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214968((Z)-2-(4-(6-(4-fluorophenyl)-4-(2-methylbenzofuran...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214968((Z)-2-(4-(6-(4-fluorophenyl)-4-(2-methylbenzofuran...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM28661(GW501516 | CHEMBL38943 | 2-{2-methyl-4-[({4-methyl...)
Affinity DataEC50:  3.90E+3nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214964((Z)-2-(2-methyl-4-(4-(4-(5-methylthiophen-2-yl)phe...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214954((Z)-2-(2-methyl-4-(6-phenyl-4-(quinolin-3-yl)hex-2...)
Affinity DataEC50:  6.60E+3nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214964((Z)-2-(2-methyl-4-(4-(4-(5-methylthiophen-2-yl)phe...)
Affinity DataEC50:  3.90E+3nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214950((Z)-2-(4-(4-(4-bromophenyl)-6-(4-chlorophenyl)hex-...)
Affinity DataEC50:  320nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214951((Z)-[4-[3-(4-4-bromophenyl)-5-(4-trifluoromethyl-p...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM28661(GW501516 | CHEMBL38943 | 2-{2-methyl-4-[({4-methyl...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214952({4-[(Z)-4-biphenyl-4-yl-6-(4-methoxy-phenyl)-hex-2...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214953(2-(2-methyl-4-(5-phenylpent-2-en-4-ynylthio)phenox...)
Affinity DataEC50:  1.40E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214954((Z)-2-(2-methyl-4-(6-phenyl-4-(quinolin-3-yl)hex-2...)
Affinity DataEC50:  290nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214955((Z)-2-(4-(4-(4-bromophenyl)-6-(4-fluoro-3-methylph...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214956((Z)-2-(4-(4-(4-bromophenyl)-6-(5-methylthiophen-2-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214957((Z)-2-(4-(4-(4-bromophenyl)-6-phenylhex-2-en-5-yny...)
Affinity DataEC50:  160nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50134840((S)-2-Ethoxy-3-[4-((E)-5-phenyl-pent-2-en-4-ynylox...)
Affinity DataEC50:  2.60E+3nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214958({4-[(Z)-4-(4-bromo-phenyl)-6-(2-methyl-1,1-dioxo-1...)
Affinity DataEC50:  1.20E+3nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214956((Z)-2-(4-(4-(4-bromophenyl)-6-(5-methylthiophen-2-...)
Affinity DataEC50:  220nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214959((Z)-2-(4-(4-(4-bromophenyl)-6-(4-(hydroxymethyl)ph...)
Affinity DataEC50:  490nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214950((Z)-2-(4-(4-(4-bromophenyl)-6-(4-chlorophenyl)hex-...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214953(2-(2-methyl-4-(5-phenylpent-2-en-4-ynylthio)phenox...)
Affinity DataEC50:  1.21E+4nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214961((Z)-2-(4-(4-(4-bromophenyl)-6-phenylhex-2-en-5-yny...)
Affinity DataEC50:  770nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214960((Z)-2-(2-methyl-4-(4-(2-methylbenzofuran-5-yl)-6-(...)
Affinity DataEC50:  150nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214952({4-[(Z)-4-biphenyl-4-yl-6-(4-methoxy-phenyl)-hex-2...)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214957((Z)-2-(4-(4-(4-bromophenyl)-6-phenylhex-2-en-5-yny...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214962((S)-3-[4-(3,5-diphenyl-pent-2-en-4-ynyloxy)-phenyl...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARalpha by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214957((Z)-2-(4-(4-(4-bromophenyl)-6-phenylhex-2-en-5-yny...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214962((S)-3-[4-(3,5-diphenyl-pent-2-en-4-ynyloxy)-phenyl...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214959((Z)-2-(4-(4-(4-bromophenyl)-6-(4-(hydroxymethyl)ph...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214963((Z)-2-(4-(4,6-diphenylhex-2-en-5-ynyloxy)-2-methyl...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARdelta by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM50214960((Z)-2-(2-methyl-4-(4-(2-methylbenzofuran-5-yl)-6-(...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human PPARgamma by transactivation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed